Berkwood Drills 90m Of Graphite During Ongoing Phase 4 Drilling And Provides An Overview Of Mise-A-La-Masse Geophysical Results At The Lac Gueret South Graphite Project

Berkwood Resources Ltd. (TSXV:BKR, FSE:BK2, WKN:A110N3) (“Berkwood” or the “Company”) is pleased to announce that drilling at its Phase 4 definition drilling program on Zone 1 at the Company’s 100% owned Lac Gueret South Project is continuing. The Program is designed to extend eastward, and to infill drill portions of, the current mineralization model: to date […]

Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that the first patient has been dosed in a Phase 1/1b clinical trial of APVO436, a novel anti-CD123 by anti-CD3 bispecific antibody based on Aptevo’s ADAPTIR technology, which is being developed for the treatment of patients with Acute Myeloid […]

Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial

Kiniksa Pharmaceuticals (Nasdaq: KNSA) a biopharmaceutical company with a pipeline of five product candidates across various stages of development, today announced interim data from an open-label Phase 2 clinical trial of rilonacept, a weekly, subcutaneously-injected, recombinant fusion protein that blocks IL-1α and IL-1β signaling, in subjects with symptomatic recurrent pericarditis. The data show reductions in both […]

Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients

Constellation Pharmaceuticals (Nasdaq:CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced an update of the ProSTAR study, its ongoing Phase 1b/2 clinical trial of CPI-1205 in patients with metastatic castration-resistant prostate cancer (mCRPC). As quoted in the press release: The ProSTAR study is evaluating CPI-1205, Constellation’s potent and […]

Eyenovia Initiates Phase III MicroStat Program for Pharmacologic Mydriasis: Enrolls First Patient in MIST-1 Study

Eyenovia (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print technology, announced that it has enrolled the first patient in the first of two Phase III trials (MIST-1 and MIST-2) of the Company’s MicroStat program for pharmacologic mydriasis, or dilation of the pupil for an eye exam. […]

Gold 7-Year Bear Market Phase Is Over

Article posted at The Market Oracle http://www.marketoracle.co.uk/Article63354.html The Market Oracle – Financial Markets Analysis and Forecasts – CLICK TO READ ARTICLE

BriaCell Announces Positive Phase IIa Proof of Concept Data in Advanced Breast Cancer; Initiates Combination Study

BriaCell has achieved positive proof of concept in the Phase IIa study of Bria-IMT in advanced breast cancer patients Data shows promising anti-tumor activity of Bria-IMT in heavily pre-treated advanced breast cancer patients Impressive Phase IIa efficacy data is similar or superior to those of other approved breast cancer drugs of similar clinical-stage of development […]

Noram Plans Next Phase of Exploration in the Clayton Valley and at Arizaro East, Argentina

Noram Ventures Inc. (TSXV:NRM / Frankfurt:N7R / OTCBB:NRVTF) (“Noram” or the “Company”) is pleased to provide an update on its exploration plans for the 2700 hectare lithium exploration project in the Salar de Arizaro, Salta, Argentina and for a Phase III drill program in Clayton Valley, Nevada. Clayton Valley, Nevada On November 21, 2017, the […]

Teck: Quebrada Blanca Phase 2 Receives Regulatory Approval

Teck Resources (TSX:TECK.A,TSX:TECK.B,NYSE:TECK) has announced that it has received regulatory approval for its Quebrada Blanca phase 2 project (QB2) in the Tarapacá Region in northern Chile. According to Teck’s release, the regional environmental committee of Tarapacá has voted to approve the project environmental impact assessment. Receipt of the environmental qualification resolution is expected in the […]

Phase 1 Exploration Program Commences at Buena Vista Hills Cobalt Project, Pershing County, Nevada

New Tech Lithium Corp (CSE:NTM) is pleased to announce that it has initiated a Phase 1 exploration program at its Buena Vista Hills Cobalt project, located 25 miles southeast of Lovelock, Nevada. The program, with an estimated budget of US $ 250,000, will consist of a review and re-interpretation of a historic airborne magnetic survey, a […]

Phase Two of Ethereum (ETH) is Coming Soon, Says Joe Lubin

Ethereum phase two: Co-founder of Ethereum (ETH), Joseph Lubin, just made a big announcement about the world’s second largest blockchain ecosystem. He spoke at the Rise conference yesterday in Hong Kong and revealed that the first layer of the Ethereum ecosystem is now complete and phase two should be finalized sometime this year. Lubin states that […]

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX2-73 for the Treatment of Parkinson’s Disease Dementia

Anavex Life Sciences (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, today announced that the Company has received approval from the Spanish Agency for Medicinal Products and Medical Devices (AEMPS), to initiate its Phase 2, double-blind, placebo-controlled 14-week trial of the safety and efficacy of ANAVEX®2-73 for […]